Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 15, 2026Reported sale · Form 4Christopher A. Kroeger, Chief Executive Officer · $595.4KOpen the filing ↗
- Oct 15, 2026Reported sale · Form 4JONATHAN GILLIS, CAO and Interim CFO · $82.1KOpen the filing ↗
- Oct 15, 2026Reported sale · Form 4James Woodruff Lillie, Chief Scientific Officer · $93.0KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year245
SEC filings on record1859 flagged findings
Reported transactions (Form 4)80since Oct 27, 2025 · and 40 other holdings
Corporate events (8-K)5since Oct 29, 2025
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Reverse splits in 5 years
1 reverse split in 5 years (1:16.81 on Oct 31, 2025) · 1:17 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 185)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
Insider transaction · 6 Form 4 filings newshow all 6hide
Notice of proposed sale · 7 Form 144 filings newshow all 7hide
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
- Sep 23, 26424B3 ↗Securities offering
- Sep 18, 26Form 4 ↗Insider transaction
- Sep 18, 26S-1/A ↗Securities offering · amendment
- Sep 16, 26Form 144 ↗Notice of proposed sale
- Sep 9, 26S-1 ↗Securities offering
- Aug 20, 26SCHEDULE 13G ↗Passive stake · Nan Fung Group Holdings Limited · 5.5% · event on Aug 13, 26
185 filings on record, the oldest from Apr 4, 24.
Listing the 25 most recent filings of the 185 on record.
32
- Aug 13, 26Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Jun 18, 26A senior executive left or was appointed8-K 5.02 ↗
- Apr 29, 26A senior executive left or was appointed8-K 5.02 ↗
- Oct 29, 25Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Catalyst4, Inc.49.9%Aug 14, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- Novo Holdings A/S4.9%Jul 30, 26SCHEDULE 13D/A ↗1 earlier filing
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- T. Rowe Price Investment Management, Inc.7.4%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
- Forbion Growth Opportunities Fund III Cooperatief U.A.7.1%Dec 31, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Nan Fung Group Holdings Limited5.5%Aug 13, 26SCHEDULE 13G ↗10 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Oct 15, Hanson Kristopher filed notice of intent to sell up to $70K. That is about 0.02% of shares outstanding.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $73K on Oct 15, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+9 more recent notices · 7 with a later sale
- Oct 15, 26Sell$595KChristopher A. KroegerChief Executive Officer↗
- Oct 15, 26Sell$82KJONATHAN GILLISCAO and Interim CFO↗
- Oct 15, 26Sell$93KJames Woodruff LillieChief Scientific Officer↗
- Oct 15, 26Sell$73KKristopher HansonGeneral Counsel↗
- Oct 15, 26Sell$124KErin Pennock FoffChief Medical Officer↗
- Oct 15, 26Sell$96KAnatol KreitzerChief Discovery Officer↗
- Sep 16, 26Sell$193KKristopher HansonGeneral Counsel↗
- Aug 14, 26Buy$50.1MCatalyst4, Inc.↗
- Aug 3, 26Sell$277KJames Woodruff LillieChief Scientific Officer↗
- Jul 30, 26Buy$13.0MCatalyst4, Inc.↗
- Jul 29, 26Buy$38KCatalyst4, Inc.↗
- Jul 28, 26Buy$149KTroy Cox↗
There are 21 more transactions in this stretch.
Stock compensation, tax and giftsshow the 7 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Aug 17, 26Compensationamount n/aChristopher A. KroegerChief Executive Officer↗
- Aug 17, 26Compensationamount n/aJONATHAN GILLISCAO and Interim CFO↗
- Aug 17, 26Compensationamount n/aJONATHAN GILLISCAO and Interim CFO↗
- Aug 17, 26Compensationamount n/aJames Woodruff LillieChief Scientific Officer↗
- Aug 17, 26Compensationamount n/aKristopher HansonGeneral Counsel↗
- Aug 17, 26Compensationamount n/aErin Pennock FoffChief Medical Officer↗
- Aug 17, 26Compensationamount n/aAnatol KreitzerChief Discovery Officer↗
The full record holds 198 transactions and goes back to Oct 25, 25.
Its sector and its market
MapLight Therapeutics, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
- Macrogenics Inc. MGNX
- Madrigal Pharmaceuticals, Inc. MDGL
- MAIA Biotechnology, Inc. MAIA
- MANGOCEUTICALS, INC. MGRX
- MannKind Corporation MNKD
- Maravai Lifesciences Holdings Inc. MRVI
- Marker Therapeutics, Inc. MRKR
- Maternus-Kliniken Aktiengesellschaft MAK
- Matinas BioPharma Holdings, Inc. MTNB
- Mauna Kea Technologies S.A. ALMKT
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From MapLight Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow MapLight Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 185 documents on file, from Apr 4, 2024 to Oct 16, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.